B

Brain+ A/S
CSE:BRAINP

Watchlist Manager
Brain+ A/S
CSE:BRAINP
Watchlist
Price: 0.0096 DKK Market Closed
Market Cap: 10.9m DKK

Brain+ A/S
Investor Relations

Brain+ A/S is engaged in the developing of medical software to detect and treat the cognitive symptoms of dementia and the most common cause of dementia, namely Alzheimer's disease. The firm focuses on the development of digital treatment for dementia and Alzheimer’s disease by digital therapeutics. The Company’s main activities include the development of Cognitive Stimulation Therapy for the treatment of dementia, Computerized Cognitive Training for the treatment of earlier stages of Alzheimer’s and Starry Night memory test for early detection and monitoring of Alzheimer’s. The company offers a product called Digital CST assistant giving access to Cognitive Stimulation Therapy sessions, available in Danish.

Show more
Loading
BRAINP
OMX Copenhagen 25
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2025
Call Date
Sep 4, 2025
Q2 2025 Earnings Call
No Analysis Available

This earnings call has not been analyzed yet.

If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.

Request Earnings Call Analysis
Earnings Call Recording
Other Earnings Calls
2025

Management

Mr. Kim Baden-Kristensen
Founder, CEO & MD
No Bio Available
Mr. Rasmus Højengaard
Founder and CCO
No Bio Available
Ms. Hanne Leth Hillman M.Sc.
Interim Chief Financial Officer
No Bio Available
Ms. Paula Petcu
Chief Technology Officer
No Bio Available
Mr. Simon Nielsen
Chief Science & Innovation Officer
No Bio Available
Mr. Bjarke Langbol Panduro
Marketing & Product Mang.
No Bio Available
Mr. Bertil Stengaard Jessen
Chief Financial Officer (Leave of Absence)
No Bio Available

Contacts

Address
COPENHAGEN
Koebmagergade 53, 3rd floor
Contacts